• Je něco špatně v tomto záznamu ?

Current Advances, Research Needs and Gaps in Mycotoxins Biomonitoring under the HBM4EU-Lessons Learned and Future Trends

P. Alvito, RM. Assunção, L. Bajard, C. Martins, MJB. Mengelers, H. Mol, S. Namorado, AD. van den Brand, E. Vasco, S. Viegas, MJ. Silva

. 2022 ; 14 (12) : . [pub] 20221124

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032594

Mycotoxins are natural metabolites produced by fungi that contaminate food and feed worldwide. They can pose a threat to human and animal health, mainly causing chronic effects, e.g., immunotoxic and carcinogenic. Due to climate change, an increase in European population exposure to mycotoxins is expected to occur, raising public health concerns. This urges us to assess the current human exposure to mycotoxins in Europe to allow monitoring exposure and prevent future health impacts. The mycotoxins deoxynivalenol (DON) and fumonisin B1 (FB1) were considered as priority substances to be studied within the European Human Biomonitoring Initiative (HBM4EU) to generate knowledge on internal exposure and their potential health impacts. Several policy questions were addressed concerning hazard characterization, exposure and risk assessment. The present article presents the current advances attained under the HBM4EU, research needs and gaps. Overall, the knowledge on the European population risk from exposure to DON was improved by using new harmonised data and a newly derived reference value. In addition, mechanistic information on FB1 was, for the first time, organized into an adverse outcome pathway for a congenital anomaly. It is expected that this knowledge will support policy making and contribute to driving new Human Biomonitoring (HBM) studies on mycotoxin exposure in Europe.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032594
003      
CZ-PrNML
005      
20230131151801.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/toxins14120826 $2 doi
035    __
$a (PubMed)36548723
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Alvito, Paula $u National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal $u Centre for Environmental and Marine Studies (CESAM), University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal $1 https://orcid.org/0000000183961357
245    10
$a Current Advances, Research Needs and Gaps in Mycotoxins Biomonitoring under the HBM4EU-Lessons Learned and Future Trends / $c P. Alvito, RM. Assunção, L. Bajard, C. Martins, MJB. Mengelers, H. Mol, S. Namorado, AD. van den Brand, E. Vasco, S. Viegas, MJ. Silva
520    9_
$a Mycotoxins are natural metabolites produced by fungi that contaminate food and feed worldwide. They can pose a threat to human and animal health, mainly causing chronic effects, e.g., immunotoxic and carcinogenic. Due to climate change, an increase in European population exposure to mycotoxins is expected to occur, raising public health concerns. This urges us to assess the current human exposure to mycotoxins in Europe to allow monitoring exposure and prevent future health impacts. The mycotoxins deoxynivalenol (DON) and fumonisin B1 (FB1) were considered as priority substances to be studied within the European Human Biomonitoring Initiative (HBM4EU) to generate knowledge on internal exposure and their potential health impacts. Several policy questions were addressed concerning hazard characterization, exposure and risk assessment. The present article presents the current advances attained under the HBM4EU, research needs and gaps. Overall, the knowledge on the European population risk from exposure to DON was improved by using new harmonised data and a newly derived reference value. In addition, mechanistic information on FB1 was, for the first time, organized into an adverse outcome pathway for a congenital anomaly. It is expected that this knowledge will support policy making and contribute to driving new Human Biomonitoring (HBM) studies on mycotoxin exposure in Europe.
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    12
$a mykotoxiny $x toxicita $7 D009183
650    _2
$a biologický monitoring $7 D000079687
650    _2
$a houby $7 D005658
650    _2
$a hodnocení rizik $7 D018570
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Assunção, Ricardo Manuel $u National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal $u Centre for Environmental and Marine Studies (CESAM), University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal $u IUEM, Instituto Universitário Egas Moniz, Egas Moniz-Cooperativa de Ensino Superior, CRL, Campus Universitário-Quinta da Granja, Monte da Caparica, 2829-511 Caparica, Portugal $1 https://orcid.org/0000000243750456
700    1_
$a Bajard, Lola $u RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 611 37 Brno, Czech Republic
700    1_
$a Martins, Carla $u National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal $u NOVA National School of Public Health, NOVA University of Lisbon, 1600-560 Lisbon, Portugal $u Comprehensive Health Research Center, CHRC, 1600-560 Lisbon, Portugal $1 https://orcid.org/0000000179302914
700    1_
$a Mengelers, Marcel J B $u National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands
700    1_
$a Mol, Hans $u Wageningen Food Safety Research (WFSR), Part of Wageningen University & Research, 6708 WB Wageningen, The Netherlands $1 https://orcid.org/0000000300876910
700    1_
$a Namorado, Sónia $u National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal $u Comprehensive Health Research Center, CHRC, 1600-560 Lisbon, Portugal $1 https://orcid.org/0000000275008811
700    1_
$a van den Brand, Annick D $u National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands $1 https://orcid.org/0000000283965494
700    1_
$a Vasco, Elsa $u National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal $1 https://orcid.org/000000018532807X
700    1_
$a Viegas, Susana $u NOVA National School of Public Health, NOVA University of Lisbon, 1600-560 Lisbon, Portugal $u Comprehensive Health Research Center, CHRC, 1600-560 Lisbon, Portugal $1 https://orcid.org/0000000310158760
700    1_
$a Silva, Maria João $u National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisboa, Portugal $u ToxOmics-NOVA Medical School, NOVA University of Lisbon, 1150-082 Lisboa, Portugal $1 https://orcid.org/0000000260600716
773    0_
$w MED00177194 $t Toxins $x 2072-6651 $g Roč. 14, č. 12 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36548723 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151757 $b ABA008
999    __
$a ok $b bmc $g 1891390 $s 1183929
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 14 $c 12 $e 20221124 $i 2072-6651 $m Toxins $n Toxins $x MED00177194
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace